Literature DB >> 32303696

Macrophages: a Trojan horse in COVID-19?

Matthew D Park1.   

Abstract

Entities:  

Year:  2020        PMID： 32303696      PMCID： PMC7186930          DOI： 10.1038/s41577-020-0317-2

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  66 in total

Review 1.  Extrapulmonary manifestations of COVID-19.

Authors:  Aakriti Gupta; Mahesh V Madhavan; Kartik Sehgal; Nandini Nair; Shiwani Mahajan; Tejasav S Sehrawat; Behnood Bikdeli; Neha Ahluwalia; John C Ausiello; Elaine Y Wan; Daniel E Freedberg; Ajay J Kirtane; Sahil A Parikh; Mathew S Maurer; Anna S Nordvig; Domenico Accili; Joan M Bathon; Sumit Mohan; Kenneth A Bauer; Martin B Leon; Harlan M Krumholz; Nir Uriel; Mandeep R Mehra; Mitchell S V Elkind; Gregg W Stone; Allan Schwartz; David D Ho; John P Bilezikian; Donald W Landry
Journal:  Nat Med       Date:  2020-07-10       Impact factor: 53.440

2.  Macrophage Responses to Environmental Stimuli During Homeostasis and Disease.

Authors:  Adil Rasheed; Katey J Rayner
Journal:  Endocr Rev       Date:  2021-07-16       Impact factor: 19.871

3.  Role of the Immune Microenvironment in SARS-CoV-2 Infection.

Authors:  Chih-Hung Ye; Wen-Lin Hsu; Guan-Ru Peng; Wei-Chieh Yu; Wei-Chen Lin; SuiYun Hu; Shu-Han Yu
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

Review 4.  COVID-19 and the immune system.

Authors:  J Paces; Z Strizova; D Smrz; J Cerny
Journal:  Physiol Res       Date:  2020-05-29       Impact factor: 1.881

5.  Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Authors:  Anne-Gaëlle Goubet; Agathe Dubuisson; Laurence Zitvogel; Lisa Derosa; Arthur Geraud; François-Xavier Danlos; Safae Terrisse; Carolina Alves Costa Silva; Damien Drubay; Lea Touri; Marion Picard; Marine Mazzenga; Aymeric Silvin; Garett Dunsmore; Yacine Haddad; Eugenie Pizzato; Pierre Ly; Caroline Flament; Cléa Melenotte; Eric Solary; Michaela Fontenay; Gabriel Garcia; Corinne Balleyguier; Nathalie Lassau; Markus Maeurer; Claudia Grajeda-Iglesias; Nitharsshini Nirmalathasan; Fanny Aprahamian; Sylvère Durand; Oliver Kepp; Gladys Ferrere; Cassandra Thelemaque; Imran Lahmar; Jean-Eudes Fahrner; Lydia Meziani; Abdelhakim Ahmed-Belkacem; Nadia Saïdani; Bernard La Scola; Didier Raoult; Stéphanie Gentile; Sébastien Cortaredona; Giuseppe Ippolito; Benjamin Lelouvier; Alain Roulet; Fabrice Andre; Fabrice Barlesi; Jean-Charles Soria; Caroline Pradon; Emmanuelle Gallois; Fanny Pommeret; Emeline Colomba; Florent Ginhoux; Suzanne Kazandjian; Arielle Elkrief; Bertrand Routy; Makoto Miyara; Guy Gorochov; Eric Deutsch; Laurence Albiges; Annabelle Stoclin; Bertrand Gachot; Anne Florin; Mansouria Merad; Florian Scotte; Souad Assaad; Guido Kroemer; Jean-Yves Blay; Aurélien Marabelle; Frank Griscelli
Journal:  Cell Death Differ       Date:  2021-07-06       Impact factor: 15.828

Review 6.  Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19.

Authors:  Danielle Brain; Alex Plant-Hately; Bethany Heaton; Usman Arshad; Christopher David; Christian Hedrich; Andrew Owen; Neill J Liptrott
Journal:  Adv Drug Deliv Rev       Date:  2021-06-25       Impact factor: 17.873

7.  Comparative Transcriptomic and Molecular Pathway Analyses of HL-CZ Human Pro-Monocytic Cells Expressing SARS-CoV-2 Spike S1, S2, NP, NSP15 and NSP16 Genes.

Authors:  Anshika Sharma; Joe W Ong; Mun Fai Loke; Eng Guan Chua; Joseph J Lee; Hyung Won Choi; Yee Joo Tan; Sunil K Lal; Vincent T Chow
Journal:  Microorganisms       Date:  2021-05-31

Review 8.  The role of estradiol in the immune response against COVID-19.

Authors:  Adrián Ramírez-de-Arellano; Jorge Gutiérrez-Franco; Erick Sierra-Diaz; Ana Laura Pereira-Suárez
Journal:  Hormones (Athens)       Date:  2021-06-17       Impact factor: 2.885

9.  Myeloid cell interferon responses correlate with clearance of SARS-CoV-2.

Authors:  Dhiraj Singh; Ekaterina Aladyeva; Shibali Das; Bindu Singh; Ekaterina Esaulova; Amanda Swain; Mushtaq Ahmed; Journey Cole; Chivonne Moodley; Smriti Mehra; Larry Schlesinger; Maxim Artyomov; Shabaana Khader; Deepak Kaushal
Journal:  Res Sq       Date:  2021-07-15

10.  Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial.

Authors:  Vinicius Fontanesi Blum; Sérgio Cimerman; James R Hunter; Paulo Tierno; Acioly Lacerda; Alexandre Soeiro; Florentino Cardoso; Nancy Cristina Bellei; Juliana Maricato; Nathalia Mantovani; Marcella Vassao; Danilo Dias; Juliana Galinskas; Luis Mário Ramos Janini; Joanna Reis Santos-Oliveira; Alda Maria Da-Cruz; Ricardo Sobhie Diaz
Journal:  EClinicalMedicine       Date:  2021-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.